AAIPharma, Inc. has entered an agreement to acquire Cvitkovic & Associes Consultants S.A. (CAC), an international CRO specializing in oncology drug development and medical consulting, creating an AAIOncology business unit. CAC performs lead assessment of new analogs of established drugs as well as novel target-oriented compounds and has developed expertise in cancer therapies, including cytotoxics, cytostatics, monoclonal antibodies, cell-based therapies, vaccines, antiangiogenic agents, apo...